Literature DB >> 4875708

Diazoxide and the treatment of hypoglycemia: an historical review.

J Black.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4875708     DOI: 10.1111/j.1749-6632.1968.tb19045.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  12 in total

Review 1.  Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical data.

Authors:  Rebecca J Brown; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2008-01-24       Impact factor: 4.866

Review 2.  Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  The management of the hypoglycemic patient.

Authors:  T Kennedy
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

4.  Antihypertensive effect of diazoxide given intravenously in small repeated doses.

Authors:  A McNair; F Andreasen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis.

Authors:  Jerod Scott Denton; David Aaron Jacobson
Journal:  Trends Endocrinol Metab       Date:  2011-11-29       Impact factor: 12.015

6.  Liver injury may increase the risk of diazoxide toxicity: a case report.

Authors:  Emir Tas; Burhanuddin Mahmood; Luigi Garibaldi; Mark Sperling
Journal:  Eur J Pediatr       Date:  2015-01-25       Impact factor: 3.183

7.  [Comparison of oral diazoxide and minoxidil in refractory hypertension].

Authors:  A Meier; P Weidmann; Z Glück; G Keusch; M Grimm; I Minder; F C Reubi
Journal:  Klin Wochenschr       Date:  1980-07-01

8.  Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas.

Authors:  I M Burr; E B Marliss; W Stauffacher; A E Renold
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

9.  Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.

Authors:  Adriana Herrera; Mary Ellen Vajravelu; Stephanie Givler; Lauren Mitteer; Catherine M Avitabile; Katherine Lord; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

10.  Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.

Authors:  J E Pohl; H Thurston; D Davis; M Y Morgan
Journal:  Br Med J       Date:  1972-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.